JAK2 and Venous thrombosis: For separate model simulations of JAK2 subgroups, the incidences of MF and thrombosis reached considerably higher levels for patients with JAK2 >50%, which might imply that possible differences in JAK2 levels across different studies could explain differences in incidence of MF and thrombosis.